Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant.
AffiliationAnu Research Centre, Department of Obstetrics and Gynaecology, University College, Cork, Cork University Maternity Hospital, Wilton, Cork, Ireland.
Fetal Diseases/*prevention & control
Infectious Disease Transmission, Vertical/*prevention & control
Pregnancy Complications, Infectious/*virology
MetadataShow full item record
CitationCochrane Database Syst Rev. 2011 Mar 16;(3):CD008371.
JournalCochrane database of systematic reviews (Online)
AbstractBACKGROUND: Cytomegalovirus (CMV) is a herpesvirus and the most common cause of congenital infection in developed countries. Congenital CMV infection can have devastating consequences to the fetus. The high incidence and the serious morbidity associated with congenital CMV infection emphasise the need for effective interventions to prevent the antenatal transmission of CMV infection. OBJECTIVES: The aim of this review was to assess the benefits and harms of interventions used during pregnancy to prevent mother to fetus transmission of CMV infection. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 December 2010). SELECTION CRITERIA: All randomised controlled trials (RCTs) and quasi RCTs investigating antenatal interventions for preventing the transmission of CMV from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed studies for inclusion. MAIN RESULTS: We identified six studies from the search. None of these studies met the pre-defined criteria for inclusion in this review. AUTHORS' CONCLUSIONS: To date, no RCTs are available that examine antenatal interventions for preventing the transmission of CMV from the infected mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Further research is needed to assess the efficacy of interventions aimed at preventing the transmission of CMV from the mother to fetus during pregnancy including a long-term follow-up of exposed infants and a cost effective analysis.
- Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus.
- Authors: Rawlinson WD, Hamilton ST, van Zuylen WJ
- Issue date: 2016 Dec
- Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
- Authors: Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD
- Issue date: 2014 Nov
- Antenatal treatment options for primary cytomegalovirus infections.
- Authors: Kagan KO, Sonek J, Hamprecht K
- Issue date: 2018 Dec
- Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
- Authors: Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M
- Issue date: 2012 Mar 27
- Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
- Authors: Nigro G
- Issue date: 2017 Nov